RESEARCH TRIANGLE PARK, N.C., Dec. 13, 2022 -- Pappas Capital, a global venture capital and commercial development firm, announced today the appointment of Richard Staub as Venture Partner. His appointment...
Liquidia begins testing flu vaccine
Liquidia Technologies has started early clinical testing of its first vaccine developed using nanotechnology.
© 2023 Pappas Capital, LLC. ALL RIGHTS RESERVED.